机构:[1]Department of Pharmacy, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, China.[2]Department of Pharmacy, The First People's Hospital of Kunming City & Calmette Affiliated Hospital of Kunming Medical University, Kunming, China.[3]Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Kunming Medical University, Kunming, China.昆明医科大学附属第一医院呼吸与危重症一科呼吸内科内科科室[4]Department of Pulmonary and Critical Care Medicine, The Affiliated Hospital of Yunnan University, Kunming, China
National Natural Science Foundation of China (No. 82160016), the Basic Research Program of Yunnan Province (No. 202201AY070001-265 and 202301AT070482), the Yunnan Health Training Project of High-Level Talents (No. H- 2019026), and the Famous Doctors of High-Level Talent Training Support Program of Yunnan Province (No. YNWR-MY-2020-013).
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2024]版:
无
最新[2023]版:
大类|2 区医学
小类|1 区药学2 区医学:研究与实验
JCR分区:
出版当年[2023]版:
Q1MEDICINE, RESEARCH & EXPERIMENTALQ1PHARMACOLOGY & PHARMACY
最新[2023]版:
Q1MEDICINE, RESEARCH & EXPERIMENTALQ1PHARMACOLOGY & PHARMACY
第一作者机构:[1]Department of Pharmacy, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, China.
通讯作者:
推荐引用方式(GB/T 7714):
Zhao Fangyun,Pan Chunhong,Zhang Yue,et al.Polyphyllin VII alleviates pulmonary hypertension by inducing miR-205-5p to target the β-catenin pathway[J].BIOMEDICINE & PHARMACOTHERAPY.2023,167:115516.doi:10.1016/j.biopha.2023.115516.
APA:
Zhao Fangyun,Pan Chunhong,Zhang Yue,Yang Jiao&Xing Xiqian.(2023).Polyphyllin VII alleviates pulmonary hypertension by inducing miR-205-5p to target the β-catenin pathway.BIOMEDICINE & PHARMACOTHERAPY,167,
MLA:
Zhao Fangyun,et al."Polyphyllin VII alleviates pulmonary hypertension by inducing miR-205-5p to target the β-catenin pathway".BIOMEDICINE & PHARMACOTHERAPY 167.(2023):115516